1. Home
  2. ARCT vs CTO Comparison

ARCT vs CTO Comparison

Compare ARCT & CTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCT
  • CTO
  • Stock Information
  • Founded
  • ARCT 2013
  • CTO 1902
  • Country
  • ARCT United States
  • CTO United States
  • Employees
  • ARCT N/A
  • CTO N/A
  • Industry
  • ARCT Biotechnology: Pharmaceutical Preparations
  • CTO Real Estate Investment Trusts
  • Sector
  • ARCT Health Care
  • CTO Real Estate
  • Exchange
  • ARCT Nasdaq
  • CTO Nasdaq
  • Market Cap
  • ARCT 298.3M
  • CTO 568.5M
  • IPO Year
  • ARCT N/A
  • CTO N/A
  • Fundamental
  • Price
  • ARCT $13.78
  • CTO $17.60
  • Analyst Decision
  • ARCT Strong Buy
  • CTO Strong Buy
  • Analyst Count
  • ARCT 8
  • CTO 3
  • Target Price
  • ARCT $52.83
  • CTO $22.33
  • AVG Volume (30 Days)
  • ARCT 474.9K
  • CTO 399.4K
  • Earning Date
  • ARCT 08-04-2025
  • CTO 07-29-2025
  • Dividend Yield
  • ARCT N/A
  • CTO 8.63%
  • EPS Growth
  • ARCT N/A
  • CTO N/A
  • EPS
  • ARCT N/A
  • CTO N/A
  • Revenue
  • ARCT $143,680,000.00
  • CTO $132,203,000.00
  • Revenue This Year
  • ARCT N/A
  • CTO $20.11
  • Revenue Next Year
  • ARCT $34.79
  • CTO $8.51
  • P/E Ratio
  • ARCT N/A
  • CTO N/A
  • Revenue Growth
  • ARCT 15.38
  • CTO 17.48
  • 52 Week Low
  • ARCT $8.04
  • CTO $16.12
  • 52 Week High
  • ARCT $25.88
  • CTO $21.15
  • Technical
  • Relative Strength Index (RSI)
  • ARCT 54.34
  • CTO 44.45
  • Support Level
  • ARCT $13.10
  • CTO $17.11
  • Resistance Level
  • ARCT $15.20
  • CTO $17.57
  • Average True Range (ATR)
  • ARCT 1.02
  • CTO 0.37
  • MACD
  • ARCT 0.07
  • CTO -0.01
  • Stochastic Oscillator
  • ARCT 55.21
  • CTO 42.58

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.

About CTO CTO Realty Growth Inc.

CTO Realty Growth Inc is a real estate investment trust company, that owns income properties comprised of approximately 2.7 million square feet in diversified markets in the United States. Its portfolio of assets consists of Income Properties Portfolio, management services, Commercial Loan and Investments.

Share on Social Networks: